Copy

March 1st, 2021


A word from DiMe's Executive Director
 

Dear DiMe Members,

As many of us start to bump up against “one year since I last…” pandemic anniversaries, it reminds us once again how much the world has changed and how quickly that can happen. 

For me, it's been one year since I traveled, spent time with friends and family beyond my immediate circle, or gone to a gym that isn’t the garage! There are also harder and more personal events and experiences that we have all missed over the last year. These are losses that are unique to each of us, but which we collectively share.

It has also been a year since health disparities, the need for innovation to save lives, and the critical role of collaboration haven’t been front-page news. As these issues have defined our lockdown zeitgeist, our field has responded with extraordinary efforts to bring the full possibilities of digital medicine to bear as quickly as possible. 

One year on, this community’s commitment to pursuing digital innovation with safety, effectiveness, and equity in mind continues to inspire me. At a point where we could all use a little more inspiration in our lives, let’s keep pushing. Together. 

Jen
 
Catch up on February 2021
 

hih and DiMe co-host a successful Digital Medicine Week 2021

 

Digital Medicine Week’s interactive concept led to a successful series of events focused on advancing innovation in evidence generation for digital health applications. Check out this recap on why digital developers should try to board Germany’s new DiGA Fast-Track process.

 

What is a benefit-risk framework for digital health technology development and deployment?

 

Eric Perakslis presented a framework and important privacy considerations for approval of digital health technologies as outlined in his recent JAMA publication, “Digital Health - The Need to Assess Benefits, Risk, and Value.” You can still watch the recording and view the presentation deck!

 

How are digital innovators improving global access to care with digital medicine?

 

CEOs Miguel Johns, Bryan Mezue, and Areva Martin joined us in a conversation with StartUp Health to describe how their companies leverage digital medicine solutions to provide healthcare to historically underserved populations. You can catch the conversation here!

 

Apply to the Research Committee!

 

DiMe is honored to welcome our new Research Committee co-chairs for 2021-2023 Isaac Rodriguez-Chavez and Ben Vandendriessche! Applications to serve on the next Research Committee with Isaac and Ben, and steer the future of research at DiMe, close on March 1. Read more about their vision for the next committee & how to apply in this blog post. 

We were thrilled to welcome DiMe's newest members during our quarterly New Member Mixer!
Get involved in March 2021

Participate in DiMe’s Equity and Access Community Roundtable Series

 

DiMe is hosting a limited series to identify solutions for addressing health disparities as part of our involvement in the HEAL Coalition. The first event is March 15 at 12-1pm ET and all DiMe members are welcome to join. Learn the specific discussion topics and sign up here!

 

DiMe and Deloitte to co-host workshop on upcoming publication, “Biopharma and Digital Health: Winning with digital medicine products.”

 

Join us March 25 to discuss the current state and see how organizations are aligning for success in the future of health, where digital medicine products will be used at scale for prevention, proactive care, and personalized therapies. Register now! 

 

Learn more about virtual-first healthcare from founding members of IMPACT

 

Join experts from ATA, Oshi, Dreem, and DiMe for a discussion on our recent launch into virtual-first care and identifying initiatives to put digital health into practice. Click here to register for the March 9 event! 

 

TMCity seeks research proposals to explore the relationship between COVID-19 and cognitive impairment/dementia 

 

TMCity is looking for proposals with an emphasis on the use of COVID-19 data regarding cognitive impairment, dementia-like symptoms, and co-morbidity issues. View the RFP here!

 

DiMe to present at SCOPE 2021

 

Join us 12th Annual Summit for Clinical Trials Operations Executives for presentations on clinical innovation, operations, and research from March 2-4, 2021 as a fully virtual event. Save $200 off the current rate. Reference discount code DIME200 upon registering.
DiMe member accomplishments
 

 

Jessilyn Dunn and Brinnae Bent published their findings from the “Digital Medicine Community Perspectives and Challenges: Survey Study.” Thank you to our DiMe community members completing the survey that informed this terrific piece on challenges to interoperability in digital medicine.

 

Ramin Rafiei co-authored the pre-print MIR publication, “Digital Health Integration Assessment and Maturity of U.S. Biopharmaceutical Industry: Forces Driving the Next Generation of Connected Auto Injectable Devices,” which examines the digital health maturity within the U.S. biopharmaceutical industry.

 

Dena Mendelsohn introduced Elektra Labs’ latest project with Carnegie Mellon researchers in the article “Why Elektra Labs is Investing in a “Nutrition Label” for Health-Tech Security and Data Rights Practices.”

 

Lucia Savage put forth a piece in Health Affairs with concrete ideas about how to modernize Medicare payment and reimbursement policy to reflect the advent of virtual care. She asserts that advancing reimbursement policy is more key to stable growth for virtual care than nearly any other policy move.

 

Inlightended, co-founded by Michelle Higginson, was featured in a Forbes piece discussing the need for diverse expertise and Inlightened's unique approach to advancing healthcare innovation.

 

Medical Travel Today (MTT) interviewed Jen Goldsack in the latest issue of the Medical Tourism and Digital Health Newsletter discussing digital medicine acumen. 

 

Ben Schwartz launched a digital health forum and discussion group on Doc.Social, a recently launched site that brings together innovators and entrepreneurs from across the healthcare and technology spectrum.  
LinkedIn
Twitter
DiMeSociety.org
Digital medicine is the future. Build it with us.
Copyright © 2020 Digital Medicine Society Inc, All rights reserved.

Our mailing address is:
90 Canal St, 4th floor
Boston, MA, 02214
USA

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.